What does “GI AE rate” mean for tigecycline?
The abbreviation “GI AE rate” usually refers to the rate of gastrointestinal adverse events (AEs) reported during treatment (for example, nausea, vomiting, diarrhea). However, the exact GI AE definition and the reported percentage depend on the specific clinical trial, dose, and AE grading scheme.
What GI side effects are typically reported with tigecycline?
Tigecycline is commonly associated with gastrointestinal AEs, especially nausea and vomiting, in clinical studies. The overall “GI AE rate” you’re asking for is not a single fixed number across all studies; it varies based on which GI AEs are grouped together (e.g., any nausea/vomiting vs. all GI AEs including diarrhea/abdominal pain) and which population is studied.
What I need to give you the exact GI AE rate
To provide the correct GI AE rate (as a specific percentage), tell me:
- Which tigecycline indication/trial you mean (e.g., complicated intra-abdominal infection, complicated skin/skin structure infection, or another study)
- Which time period you want (during treatment only vs. including follow-up)
- Which GI AEs to include (often nausea + vomiting, or “all GI AEs”)
If you share the study name, NCT number, or the label section you’re using (e.g., “Adverse Reactions” from the prescribing information), I can report the exact GI AE rate from that source.